BioCentury
ARTICLE | Financial News

Cellectis S.A amends follow-on

March 16, 2015 7:00 AM UTC

Cellectis S.A. (Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date announced: 2015-03-10 Type: Follow-on To be raised: TBD Shares: TBD Price prior: EUR12.53 Underwriters: BofA M...